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Summary 
Brucellosis 1s one of the most common worldwide zoonos1s caused by a facultative 
intracellular gram negative coccobacilli of the genus Brucella. It affects a wide range of 
mammals and induces abortion and sterility causing huge economic issue. Bruce/lais a furtive 
bacteria generating a chronic disease if not treated. At this time, no treatment nor safe or 
effective human vaccines exist. 
In this master thesis, we demonstrated that Bruce/la melitensis persists in a CDl lc+ reservoir 
cells able to resist to protective memory response in wild type C57B/6 mice. Surprisingly, the 
co-infection by the parasite Trypanosoma brucei appears able to increase the immune control 
of chronic Brucella infection. Following co-infection, the mice become able to eliminate 
Bruce/la thanks to a CD4+ T cells dependent Thl immune response, as demonstrated by using 
IL-12 and IFNy deficient mice. This mechanism is not antigen specific as T . brucei co-
infection is also able to favor the elimination of B. suis and B. abortus and that T. cruzi co-
infection display a similar effect on B. melitensis . 
Another central point of this work was to characterized Brucella's dissemination following 
several route of infection. We highlighted the fact that the route of dissemination affects the 
dissemination and could thus affects the pathology of brucellosis . 
Mémoire de master 120 en biochimie et biologie moléculaire et cellulaire 
Janvier 2017 
Promoteurs: E. Muraille 
J-J. Letesson 
Université de Namur 
FACULTE DES SCIENCES 
Secrétariat du Département de Biologie 
Rue de Bruxelles 61 - 5000 NAMUR 
Téléphone: + 32(0)81.72.44.18 - Téléfax:+ 32(0)81.72.44.20 
E-mail: joelle.jonet@unamur.be - http://www.unamur.be 
Impact de l'infection par Trypanosoma brucei sur le contrôle de l'infection par 
Bruce/la melitensis chez la souris 
VAN VYVE Margaux 
Résumé 
La brucellose est une des zoonoses les plus courantes dans le monde. Cette pathologie est 
causée par une bactérie gram négative intracellulaire facultative du genre Brucella. Une large 
gamme de mammifères peuvent être touchés par cette maladie qui induit l'avortement ainsi 
que la stérilité chez les animaux causant de graves problèmes économiques. Brucella est une 
bactérie furtive qui, non traitée, induit une maladie chronique. A l'heure actuelle, il n'existe 
pas encore de traitement ni the vaccin sûr et efficace pour l'homme. 
Durant ce mémoire, nous avons démontrés que Brucella melitensis persiste dans dans cellules 
réservoirs CDl lc+ capable de conférer une résistance face à la réponse mémoire protectrice 
dans des souris wild type C57BL/6. De façon surprenante, une co-infection avec le parasite 
Trypanosoma brucei permet d 'améliorer le contrôle de l'infection chronique générée par 
Brucella. Suite à une co-infection, la souris devient capable d'éliminer Brucella grâce à une 
réponse immunitaire de type Thl dépendante des lymphocytes T CD4+, comme démontrer en 
utilisant des souris déficientes poour l' IL-12 et l'IFNy. Ce mécanisme n'est pas antigène 
spécifique sachant qu'une co-infection avec T. brucei est également capable de favoriser 
l'élimination de B. suis et de B. abortus mais aussi qu'une co-infection avec T. cruzi présente 
un même effet sur B. melitensis. 
Un autre point central de cette étude est la caractérisation de la dissémination de Brucella 
suivant différents modes d'infection. Nous avons pu observer que la voie d'infection 
impactait fortement la dissémination et pourrait donc jouer sur l'expression de la pathologie 
de la brucellose. 
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1 ntrod uction 
lndividual variability 
Individual variability is a very important element to assure the robustness of populations and 
species to natural selective pressures. Every single individual has a different response to 
infection and present his own capacity to adapt to. Identify the at-risk persan for an epidemic 
could lower the mortality risk but to do so, the implicated factors in this susceptibility to face 
an infection must to be identify. On the other band, some persans are resistant to infection. 
Different factors are already known to have an effect on the ability of the host to control an 
infection. The most obvious parameter is the genetic variability that determine the ability to 
develop an effective immune response. Other elements also are taken into account. The 
microbiota, depending on the diet, but also the immune history of the host can influence the 
ability of the persan to face the infection. 
The microbiota is composed by the micro-organisms colonizing the host from its birth. It is a 
community of fungus, bacteria and viruses modeling the immune response and thus, 
influencing the ability of the host to face an infection (Kitano & Oda 2006; Cerf-Bensussan & 
Gaboriau-Routhiau 2010). It has been shown that "germ-free" mice were more susceptible to 
an infection, indicating the role of the microbiota in the maturation of the immune system 
(Buffie & Pamer 2013). The microbiota also protects from the infections by competition with 
pathogenic. Microbiota competes with the pathogens on different fields: for the nutrients, by 
producing taxie compounds or by making less accessible the structure facilitating the 
adherence of the pathogen to the epithelium. But the microbiota can also trigger a cross-
reactive immune response facilitating the elimination of the pathogen (Zeng et al. 2016). 
The microbiota is not the only element to act on the individual ability to face an infection: the 
immunological background of the host also plays a great role in this variability . Many 
epidemiological and experimental studies have shown that the vaccination or the exposition to 
an infection modify the immunological status and allow the host to be more resistant to other 
infection even when the host is free from the infectious strain. It is called "heterologous 
immunity" (Welsh & Selin 2002). As an example, the Bacillus Calmette-Guérin (BCG) 
vaccin gives protection against tuberculosis but also against secondary infections like Listeria 
monocytogenes (Blanden et al. 1969), Staphylococcus aureus (Sher et al. 1975) and 
Plasmodium yoelii (Matsumoto et al. 2000). 
With the immune history, the cross pathologies are another important point. When an 
infection occurs, the host is rarely naive. It is usual in nature to be co-infected by several 
pathogens at the same time. Almost everybody is concemed by latent infections like those 
caused by the herpes virus, Epstein-Barr virus, Plasmodium falciparum or Mycobacterium 
tuberculosis. Those cross-pathologies influence the immune status of the host on different 
ways like the alteration of the tissue architecture and the modification of the metabolism of 
the host cell but also the activation or inhibition of the protective immune response 
(Hakansson et al. 1994; Potian et al. 2011; Lokken et al. 2014; Furman et al. 2015). 
While my master thesis we worked on the cross-pathologies aspect of the individual 
variability during an epidemic. This aspect is little studied but it is a very common condition 
of an immunological response. It is also important to be able to predict the behavior of a host 
when he is facing a co-infection and in a therapeutic interest, to determine the protection 
mechanisms and susceptibility markers . That could lead to identify individuals responsible for 
a big part of the dissemination and thus, responsible for the spread of the pathogen. In this 
model, we study the impact of cross-pathologies on a disease affecting many individuals, 
humans and animals included, covering a large part of the globe and furthermore persisting in 
the host in absence of a treatment. Taking all this into account, brucellosis is a well-fitting 
model. 
Bruce/la 
Bruce/la: the causative agent of brucellosis 
Brucella is a gram negative a-proteobacteria and the causative agent of a chronic infectious 
disease: brucellosis. This pathogen is a facultative intracellular coccobacillus. The gender 
Brucella is divided into 12 species and each are specific for a mammalian host but this 
specificity is not stringent (Table 1) . 6 of them are able to infect accidentally humans. The 
main species infecting humans are B. melitensis, B . abortus and B. suis. Brucellosis , also 
known as Malta's fever, is a worldwide spread zoonosis with more than 500.000 new human 
cases diagnosed per year (Pappas et al. 2006) but this incidence is widely underestimated 
because of the difficulty of access to healthcare in some endemic countries but also because 
of the variability of symptoms. The most concerned regions are Central America, South 
America, Middle-East, Africa and West Asia but also in southern Europe (Figure l)(Pappas 
et al. 2006; Medzhitov 2007; Corbel 1997). 











Sheep, goat, camel 
Cattle, buffalo, elk, yak, camel 




Porpoise, dolphin, wale 
B. microti Fox, vole 
B. pinnipedialis Orca 
B. papionis Monkey 
B. vu/pis Fox 
B. pyxicephali Buffalo toad 
Table 1: Brucella species and their preferential hosts 
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Figure 1: Incidence of human brucellosis worldwide (!rom (Pappas et al. 2006) ) 
Brucellosis: symptoms and transmission 
# •••• 
The human form of brucellosis is characterized by an undulant fever specific of the acute 
phase. Without treatment, the disease enters into a chronic form with debilitating 
complications such as encephalitis, meningitides, endocarditis, arthritis, and in some cases it 
can conduct to abortion (Schneider et al. 2011). It is estimated that only 10 to 100 bacteria are 
enough to infect humans, combined with its ability to aerosolize makes Brucella a potential 
bioterrorism agent (De Figueiredo et al. 2015). Humans can be infected by different routes: 
ingestion of contaminated unpasteurized milk or cheese, skin contact and inhalation of aerosol 
(Atluri et al. 2011). 
The animal form of brucellosis is characterized by abortion in females and sterility in males. 
Brucella is known to have a tropism for trophoblastic cells (Saenz et al. 2008) and for the 
placenta in pregnant mice causing the destabilization of the homeostasis and the death of the 
fetus. The animal contamination can be either horizontal: the most frequent and due to the 
aerosol produce during the abortion or the contamination of the food and the water by 
animais' secretion, either vertical by the ingestion of contaminated milk (Diaz Aparicio 
2013). In endemic region, the economic cost due to the loss of milk production and the 
abortion can be significant (Seleem et al. 2010) . 
Diagnostic 
In Belgium, 5 to 10 new human cases of brucellosis are diagnosed each year (Infectious 
diseases of Belgium, Stephan Berger, Ed. Guideon 2015, p. 63). The disease can be diagnosis 
by an isolation of the bacteria in corporal fluid such as the blood, cerebrospinal fluid and 
synovial fluid. This technic is not very effective and an alternative exists: the serological test. 
It consists on testing the presence of anti-Brucella's LPS antibody in the serum. (details in the 
"Manual of diagnostic tests and vaccines for terres trial animais", 2016, pub li shed by the 
. 
IAO). A combination of several tests is still recommended because of the low sensibility of 
those test but also because of the cross-reaction that can be observed following an infection 
with Yersinia enterolitica 09 (Ducrotoy et al. 2016). 
Existing treatments and vaccines 
In endemic regions, animals can be vaccinated to prevent risk of infection. There are two 
main vaccine strains that are both life-attenuated: S19 strain for bovine vaccination and Revl 
for ovine and caprine vaccination. Those vaccines can induce abortion and infect humans. 
Furthermore, Revl is streptomycin resistant which is an antibiotic used to cure virulent strains 
(Garcia-Yoldi et al. 2006). Those vaccines induce anti-LPS antibody that can interfere with 
the diagnostic tests (Makala et al. 2002). 
lnfected animals are euthanized to restrict the spread of the bacteria. Infected humans have to 
take a combination of two antibiotics (doxycycline and rifampicin) during 6 to 8 weeks to 
avoid complications . Those medicines control the division of the bacteria and limit the risk of 
relapse. 
Discovery of brucellosis 
David Bruce is the first man to characterized Bruce/la in 1850 during Crimean War. He 
isolated the bacteria from the spleen of soldiers who <lied from an unknown pathology 
characterized by an undulant fever. He first named the pathogenic agent as Micrococcus 
melitensis. Half a century later, in 1905, Bruce/la melitensis is isolated from the milk of a 
contaminated goat highlighting its zoonotic feature (Seleem et al. 2010). 
The first reliable hint of brucellosis cornes from bones from the 10th to 13th centuries with 
typical lesions of brucellosis or tuberculosis that were found in ancient Albanian cities. 
Genetics analysis revealed the presence of Brucella's DNA showing that brucellosis was 
endemic in those regions at that time (Mutolo et al. 2012). 
lntracellular trafficking of Bruce/la 
The intracellular traffic of Bruce/la bas been described in macrophages and dendritic cells in 
vitro: the bacteria is opsonized or phagocyted by the cells. Inside the cell, Bruce/la resides in 
a vacuole, called Bruce/la containing vacuole (BCV) , carrying early endosome marks. Fusion 
with late endosome and lysosome acidifies the vacuole and this acidification induces the 
expression of virB operon which encodes for the type IV secretion system (T4SS). T4SS is a 
virulence factor allowing the liberation of effectors in the cytoplasm of the host cell that 
deflect the intracellular traffic of the cell (Billard et al. 2008; Marchesini et al. 2011; De Jong 
et al. 2008) . After 4 to 6 hours, the bacteria then reach the endoplasmic reticulum before 
starting to replicate (Deghelt et al. 2014) . 72h post infection, some bacteria reside in a double 
membrane compartment with autophagy markers that allowed Bruce/la to leave the cell to 





Figure 2: Intracellular trafficking of Brucella (jrom (Starr et al. 2008)) After its entry in the host cell, 
Brucella resides in a vacuole: Brucella Containing Vacuole (BCV) which merges with an early endosome 
to become an early BCV and then with a late endosome to tum into an intermediate BCV that fuses with a 
lysosome. This vacuole interacts with the exit site of the endoplasmic reticulum (ERES) in order to forma 
replicative BCV providing an environment conducive to Brucella 's replication. 
Brucel/a's niche 
Bruce/la is a furtive pathogen causing chronic disease due to its ability to persist in cells that 
we called "reservoir cells" . Those cells seem give a protection against the immune system and 
to be favorable to the replication of the bacteria. Following an intraperitoneal infection, 
B. melitensis infects principally the dendritic cells and the macrophages in the spleen: the 
macrophages of the red pulp and the metallophilic macrophages of the marginal zone 
(MMMs). As the infection evolve into its chronic phase, the infected cells are mainly 
localized in the white pulp of the spleen (Copin et al. 2012). The reservoir cells have been 
described in the spleen of susceptible IL-12p40·'· mice, following an intranasal infection. They 
presented a specific phenotype such as the expression of CDl lc and CD205 receptors whose 
are markers of the dendritic cell (DC) population. These cells are distinct from classical 
myeloid-related CD8a - CDllb+ DC present in the spleen of naive mice and from CDllb+ 
inflammatory DC present during the acute phase of infection by the absence of CD 11 b and 
F4/80 staining. These reservoir cells are also distinct from the CD8a+ DEC205+ lymphoid-
related DC subset located in the T cell area of naïve mice. The infected cells possibly derive 
from the marginal zone and differentiate from MOMA-1 + MMM (metallophilic marginal zone 
macrophages) and ER-TR9+ MZM (marginal zone macrophages) because of their expression 
of MOMA-1 or SIGN-Rl/ER-TR9. Those cells display also other specific markers such as 
Bodipy (indicating a high lipid content) and arginase 1 (Hanot Mambres et al. 2015) (Figure 
4) (Boxl). 
1 () 
Box 1: Phenotypic markers of macrophages 
Macrophages are part of a heterogeneous cell population polarizing in response to local 
stimuli. It exists two main phenotype of macrophages: Ml and M2, based on the 
receptors expressed, the cytokines and the effector molecules produced but also on their 
function. 
Pro-inflammatory or Ml macrophages are induced by IFN-y which can be combined 
with TNF, LPS but also with Granulocyte Macrophage Colony Stimulation Factor (GM-
CSF). Those cells are inducer and effector cells in the Thl inflammatory response. 
Activated Ml macrophages express a high level of IL-12 and IL-23 and metabolize 
arginine into NO which secreted along with inflammatory cytokines (Brown et al. 
2009). 
The activation of M2 macrophages is induced by diverse cytokines: IL-4, IL-13 and 
IL-1 O; by glucocorticoid and also by immune complex. When activated those cells 
express a high level ofIL-10 and via the metabolization of arginase, produce omithine 
which is involved in a Th2 response. M2 macrophages facilitates tissue repair (Verreck 
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Figure 3: Macrophages Ml and M2 polarization IFNy, LPS combined with 
TNF or GM-CSF induce the polarization into Ml macrophages. When activated , they 
express inflammatory mediators. The presence of immune compexes, IL-4, IL-13, IL-10 
induce the polarization into M2 macrophages. In their activated , those repairing tissue 
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Figure 4: Phenotype of reservoir cell of Bruce lia characterized in susceptible mice 
Particularities of Bruce/la suis, abortus and melitensis 
B. melitensis preferentially infects sheeps and goats whereas B. abortus is a bovine pathogen 
and B. suis is a swine pathogen. B. melitensis is known to be the most pathogenic one for 
human , followed by B . suis (Young 2002). In the literature, little can be found about the 
pathogenic differences in mice between the different strains of Brucella. Following an 
intranasal mode of infection in mice, it bas been observed that B. abortus and B. suis are able 
to persist longer than B. melitensis in the lungs . 
Conceming the dissemination of Brucella in rnice, it bas been shown that following the route 
of infection the bacteria behavior is different. Splitter' s tearn bas shown that following an 
intraperitoneal injection, B. melitensis is found almost instantaneously in almost every organ 
(Rajashekara et al. 2005) and our team bas shown that following more physiological route of 
infection like the intranasal infection, B. melitensis resides in the lungs and only 5 days after 
the infection the bacteria can be found in the spleen and in the liver (Hanot Mambres et al. 
2015) but also that following an intradermal infection , the bacteria was found in the lesion in 
early tirnes and only after 5 days, in the spleen and in the liver (A. Demars , 2015). 
lt could be interesting to investigate more the differences between the different species in a 
multi-organ way. 
Immune response against Bruce/la 
The innate immune system is able to detect the presence of pathogens by the recognition of 
conserved demains , called PAMPs (Pathogen Associated Molecular Patterns) , by receptors 
specific of those demains: the PRRs (Pattern Recognition Receptors). Once the pathogen is 
identified, an inflammatory response coupled with an adaptive immune response is triggered. 
Brucella bas established different strategies to escape the immune system; this furtive 
bacterium is able to limit the expression of P AMPs but also to modify their structure to lower 
the recognition by the PRRs (Gorvel 2008). For example, the lipopolysaccharide (LPS) of 
Brucella contains a longer O-chain that causes a hindered limiting the recognition by the Toll-
Like Receptor 4 (TLR4) (Cardoso et al. 2006) . The bacteria express no pili nor fimbriae and 
capsule that are also elements detectable by the immune system (Martirosyan & Gorvel 2013) 
and the flagellin expressed by Brucella contains no recognition domain for the TLR5 
(Terwagne et al. 2013). When in the host cell, Brucella is able to inhibit the development of 
the immune response. For example, Brucella abortus expresses two proteins: Brucella Tir-
containing protein 1 and 2 (Btpl, Btp2), presenting homologies with TLR and thus, 
interfering with the pathways of TLR2 and TLR4. As a consequence of that, infected 
dendritic cells have a lower maturation and activation decreasing the production of pro-
inflammatory cytokines such as Tumor Necrosis Factor a (TNFa) and interleukin-1 2 (IL-12) 
(Cirl et al. 2008; Salcedo et al. 2008). 
Despite all the mechanisms designed by this furtive bacterium to escape the immune system, 
some receptors are still able to detect this pathogen and trigger an immune response. For 
1 ') 
example, NLCR4, a cytosolic receptor, detects the flagellin of the bacterium (Terwagne et al. 
2013). 
The immune response against Brucella following an intranasal infection triggers an IL-17RA 
dependent immune response in the early stage of infection in the lungs and it represents the 
first line of defense against the pathogen. The production of interleukin-17 (IL-17) by Th 17 
lymphocytes is triggered by the secretion of IL-12, IL-23 and IL-27 by dendritic cells and 
macrophages (Ulrich E. Schaible and Albert Haas, Ed. Wiley Blackwell, pp. 220-221). IL-17 
targets the neutrophils and induces their migration, maturation and activation starting a local 
inflammatory response. However, a deficiency of IL-17RA bas only a rninor impact on the 
first days of Brucella infection and is rapidly counterbalanced by the Thl immune response 
(Pasquevich et al. 2011; Hanot Mambres et al. 2016). 
The effective primary immune response against Bruce/la during the plateau stage of the 
infection in the spleen is mainly an IFNy dependent Thl immune response. This response is 
initiated by the presentation of the rnicrobial antigens by the major histocompatibility 
complex II (MHCII) and the secretion of interleukin-12 (IL-12) by the infected cells (mainly 
macrophages and dendritic cells) to the naïve CD4+ T cells inducing their activation and 
differentiation. IFNy production by the CD4+ T cells leads to the secretion of antimicrobial 
effectors such as nitric oxide (NO) by myeloid cells (Vitry et al. 2014). These results have 
been obtained by using genetically deficient mice for IL-12 and MHCII (CD4+ T cells 
activation). Those mouse were susceptible to Bruce/la infection when TAPI (CD8+ T cells 




Transporter Associated with the Antigen Processing 1. Subunit for a 
transporter involve in the delivery of peptide across the RE membrane 
to class I molecules. 
➔ Defective in the assembly and in the transport of class I molecules. 
Their cells expressed a severe reduced level of MHC I and thus, 
deficient in the activation of CD8+ T cells. 
Gene encoding for a subunit of IL-12 (IL-12p35). IL-12p35 and is 
involve in the induction ofIFNy and in the Thl immune response. 
Major Histocompatibility Complex II. Receptor involve in the 
presentation of peptides of extracellular proteins to CD4+ T cells. 
➔ CD4+ T cells in the thymus but they are not able to maturate. 
Table 2: Deficient mice and impact of the deflciency 
Protective immune response against secondary infection with Bruce/la 
After a first contact with Bruce/la, the host is able to better control the pathogen thanks to a 
protective memory immune response. Following an intranasal inoculation, secondary 
infection is principally controlled in the lungs: the immunized mice show a bacterial load 60% 
lower in the spleen than primary infected. The CD4+ T cells keep an important role in the 
control of a second infection in mice (Hanot Mambres et al. 2016). It is interesting to note that 
cos+ T cells also play a role upon a secondary intranasal infection in this model (Hanot 
Mambres et al. 2016; Clapp et al. 2016). Other studies have shown that in an intraperitoneal 
secondary infection model, circulating specific antibodies have a crucial role in the control of 
the dissernination of Brucella but that in this case, but there is also an important role of CD4+ 
T cells and the MyD88/IL-12p35 signaling pathway (Vitry et al. 2014). The nature of the 
protective immune response seems thus to be depend on the mode of infection. 
Brucellosis is a chronic disease which if untreated leads to diverse complications such as 
endocarditis, osteoarthritis and neurological disorders. Suggesting that extemal factors like 
the co-infection are able to influence the control of the pathology, we develop different model 
of cross-pathologies and in this case, we studied the impact of Trypanosoma brucei on the 
ability of mice to control Brucella's infection. Trypanosomiasis induces a strong 
inflammatory response and we aim to destabilize the furtivity of Brucella, which is little 
inflammatory, by triggering a strong inflammatory response. 
Trypanosoma brucei 
Trypanosoma brucei: ID and disease 
Sleeping sickness or Human African Trypanosomiasis (HAT) is a vector-bome disease due to 
a flagellate protozoan: Trypanosoma brucei. This parasite belongs to the Trypanosomatidae 
family and to the Trypanosoma genus. lt has the structure of a eukaryotic cell with a tubular 
mitochondria and a kinetoplast containing the circular mitochondrial DNA. lt exists a large 
panel of Trypanosoma species but Trypanosoma brucei is the only species that causes HAT. 
Tyrpanosoma brucei can be divided on 3 different subspecies: Trypanosoma brucei brucei, 
Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense . T. brucei infects 
mammalians but only T. brucei gambiense and T. brucei rhodesiense infect humans. 
The most concemed regions by this disease are rural regions of sub-Saharan Africa. Sleeping 
sickness, or Nagana as it is called for animals , is transmitted from an infected mammalian to 
another via the bite of a carrying Tsetse fly but the mother-to-child infection also occurs 
because of the capacity of the parasite to cross the placenta. 
Millions of people in sub-Saharans countries are concemed by the disease and many of the 
affected population live in remote rural areas with limited access to health services. It 
complicated the diagnosis but also the treatment and the surveillance of the disease. 
The human trypanosomiasis exists under two different forms depending on the subspecies 
causing the disease: T. brucei gambiense cracks down in 24 countries in west and central 
Africa and this subspecies represented 98% of the human cases of trypanosomiasis . lt causes 
chronic infection with detectable symptoms that occur few months to years after being 
infected. It is mostly too late for the patient who is already in an advanced stage of the 
disease. T. brucei rhodesiense can be found in 13 countries in eastem and southem Africa and 
unlike T. brucei gambiense, it causes an acute disease and the fust symptoms occur weeks to 
months post infection but this form of the disease knows a rapid development into the central 
nervous system stage. Animals can host the humans ' pathogens and act as a reservoir, 
especially for T. brucei rhodesiense but it is also true for T. brucei gambiense. 
The development of the disease is divided onto two stages: the haemo-lymphatic stage 
corresponding to the multiplication of the parasite in subcutaneous tissues, the blood and the 
lymph and with intermittent fever, and the neurological or meningo-encephalic stage when 
the parasite has cross the brain-blood barrier. This stage has more obvious symptoms such as 
a change of behavior, confusion, sensory disturbance , coordination problem but also 
disturbance of the sleep cycle giving its name to the pathology. 
Lite cycle of T. brucei 
Trypanosoma brucei is an extracellular parasite that needs a part of its life cycle in a 
mammalian host but also a part in a Tsetse fly of the genus Glossina . By taken the bite by a 
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Tsetse fly of an infected mammalian as the first step of the cycle, the parasite enters into the 
midgut of the fly along with the blood meal into the bloodstream trypomastigote stage. It then 
differentiates into procyclic trypomastigote and starts a division . After a journey through the 
fly, the parasite reaches the salivary glands where it turns into an attached epimastigote which 
is able to complete its life cycle part into the Glossina by an asymmetric division generating a 
metacyclic trypomastigote: the mammalian ' s adapted form. The infection of a mammalian 
hast bitten by a carrying Tsetse fly allowed the rest of the life cycle. Following the bite , 
metacyclic trypomastigotes that are in the bloodstream of the hast turn into the so-called 
bloodstream trypomastigote which is able to multiply but also to cross the blood vessel 
endothelium in order to colonize extravascular tissues including the central nervous system 
(Langousis & Hill 2014; Vickerman 1985) (Figure 5) . 
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Figure 5: Life-cycle of Trypanosoma brucei inside human host and Tsetse fly (Jrom A. de Silva 
and M. Moser, Centers for Disease Control and Prevention) The blood form of Trypanosoma brucei is 
ingested by the Tsetse fly along with the blood while taking a blood meal. In the midgut of the fly , T. 
brucei tums into its procyclic trypomastigote form and multiply in a binary fission way. lt then transforms 
into an infectious stage and migrates to the salivary gland where it multiplies and tums into a metacyclic 
form that will be injected in the bloodstream of a mammalian host during the next blood meal of the Tsetse 
fly. When in the bloodstream , T. brucei tums into the bloodstream trypomastigote form and reach other 
body fluid (blood, lymph and cerebrospinal fluid) where it multiplies itself by binary fission. 
Immune response against T. brucei 
During T. brucei infection, the surface glycoproteins allowed the immune system to detect the 
presence of the parasite and to trigger an immune response against it. A strong Thl immune 
response depending on the B cells lymphocytes is induced by the recognition of those Variant 
Surface Glycoprotein (VSG). Macrophages and dendritic cells exposed the VSG via MHCII 
to the T cells lymphocytes to trigger the Thl immune response. This response is characterized 
by a strong production of IFNy by the CD4+ T cells. Activated macrophages produce 
antimicrobial factors such as TNFa and oxygen-derived reagents (H2O2) and nitrogen (NO) 
(Pays et al. 2006; Namangala et al. 2001). 
T. brucei is able to escape the immune system by switching its VSG every 5 days, translated 
by peak of parasitaemia (Hom 2014). About 2000 genes implicated in the VSG are encoded 
in T. brucei's genome but only one form is expressed at once (Mugnier et al. 2015). The 
recognition of the surface glycoproteins induces antibodies production, lgMs and IgGs, 
specific to those proteins. The parasite is able to change its glycoproteins in response to the 
immune pressure making it invisible to the immune system until it produces new antibodies 
(Marcello & Barry 2007). 
lmmunosuppressive effect of T. brucei 
Trypanosoma brucei is known to induce an immunosuppressive effect. The 
immunosuppressive effect revokes the protective responses induced by vaccines but also 
prevent the development of a B cells-mediated memory response which causes a public health 
issue in countries where African trypanosomiasis is endemic (Radwanska et al. 2008). It has 
been shown that mice infected by T. brucei present a declining antibody response as the 
infection progresses until a low rate of lgM anti-VSG (Sacks & Askonas 1980). Radwanska 
highlighted that Trypanosoma's infection provokes a rapid destruction of the splenic 
architecture inducing a loss of the germinal center formation needed for the maturation of the 
B cells lymphocytes (Radwanska et al. 2008). 
Diagnosis 
A diagnosis of the disease during the early stage of infection is crucial knowing that the late 
stage of infection is characterized with a high rate mortality even treated. For T. brucei 
gambiense a massive screening of the population is allowed by the Card Agglutination Test 
for Trypanosomiasis (CATI). This technic tests the presence of Trypanosoma specific 
antibody in the blood, the serum and the plasma (Pansaerts et al. 1998). As a first step of the 
diagnosis, this test is very interesting because it is cheap and allow the screening of many 
patients at once. lt also has a high sensitivity (87-98%) but a positive result needs to be 
confirm (lnojosa et al. 2006). The presence of the parasite has to be confirmed by microscopie 
observation of body fluids such as the blood, the lymph and the cerebrospinal fluid (Chappuis 
et al. 2005). This diagnosis is also true for T. brucei rhodesiense. The last and significant step 
of the diagnosis is the determination of the stage of the disease. To do so, a cerebrospinal 
fluid puncture needs to be performed to see if the parasite had already reach the central 
nervous system and enter into the neurological stage of the disease (Kennedy 2013). 
Treatment 
The treatment depends on the stage of the patient. For a patient in the fust stage of the 
disease , a safer and easier to administer treatment is preferred but a follow-up every 6 months 
for 24 months needs to be perform. For patient in the second stage of the disease the treatment 
is highly toxic and needs to cross the blood-brain barrier (Kennedy 2013). 
Pentamidine and suramin are the treatments use for patients in early stage of the disease . 
Suramin is used as a fust line treatment in case of an infection with T. brucei rhodesiense and 
as a second line treatment when trypanosomiasis is due to T. brucei gambiense. Whereas 
pentamidine is a first line treatment for T. brucei gambiense and a second line treatment for T. 
brucei rhodesiense. Pentamidine is effective but has side effects such as cardiac and 
gastrointestinal disordes, hyperglycaemia or hypoglycaemia and hypotension (Kennedy 
2013). Suramin is an effective treatment especially when taken very early but also has its side 
effects like renal failure, skin lesions, neurological complications, anaphylactic shock, bone 
marrow toxicity. Those early stage treatments are more effective when combined. 
The medicines use for treating the late stage of the disease are highly toxic. The most toxic is 
the melarsoprol, the only one effective for the neurological stage of T. brucei rhodesiense. 
This arsenic-based drug cause encephalopathy such as cerebral edema (Baker et al. 2013) and 
lead to death on 5% of cases. For T. brucei gambiense, a combination of eflornithine and 
nifurtimox is used. It has a lower death rate than melarsoprol of 0.7% and the side effect are 
also less severe. The use of eflornithine and nifurtimox causes bone marrow toxicity, 
alopecia , seizures and gastrointestinal symptoms (Kennedy 2013). 
In a vector-borne disease, the best treatment is still the prevention by avoiding the vector. 
Trypanosoma cruzi 
Another important protozoan's pathology is Chagas' disease caused by Trypanosma cruzi. It 
could also a well-fitting model to study the cross-pathologies implication in the individual 
variability. 
Trypanosoma cruzi is the causative agent of Chagas' disease that rages in the Americas. 
About 60.000 new cases of this parasitic disease occur each year. In contrast to T. brucei, T. 
cruzi is an intracellular parasite that is transmitted via the contaminate feces of a triatomine 
bugs which is the vector the disease, blood transfusion, organs transplant but also congenitally 
(Rassi et al. 2010). The life cycle of the parasite begins when a bug bites an infected 
mammalian host, the parasite is ingested under its trypomastigote form along with the blood. 
In the midgut of the bug, T. cruzi turns into an intermediate form called epimastigote. The 
epimastigote migrates in the bug and turns into the metacyclic trypomastigote form that will 
be excreted with feces (Figure 6). The metacyclic trypomastigote enters into the host through 
the bite site or mucous membranes. Once inside the mammalian host, it is able to invade 
several types of nucleated cells and differentiate into its intracellular form: the amastigote. It 
replicates every 12 hours for 5 days and then turns into a trypomastigote. The cell then breaks 
allowing the parasites to invade new cells and start new replicative cycle (Burleigh & 
Andrews 1995; Bern et al. 2011). 
Chagas' disease: symptoms, diagnosis and treatment 
Chagas ' disease presents different clinical aspects such as an acute phase, a chronic phase and 
a congenital form. An incubation of 1 to 2 weeks occurs before the acute phase which lasts 8 
to 12 weeks (Rassi et al. 2010). This phase is characterized by circulation hypomastigotes that 
are detectable by microscopy of the blood. Most patients are asymptomatic or have mild and 
non-specific symptoms like fever which makes the control of the parasite difficult. 20 to 30% 
of the patients have typical symptoms like inflammation and swelling at the site of infection 
called "Chagoma" and less than 1 % of the infected population declare severe symptoms such 
as myocarditis, pericardial effusion and meningoencephalitis (Acquatella 2007; Bern et al. 
2011). 
The chronic phase of the disease occurs 8 to 12 weeks post infection when the parasite 
become invisible in the blood and thus undetectable by microscopy but patients remain a 
reservoir and still have the potential to transmit the disease. After years of infection, patients 
develop cardiac and digestive disorders (Rassi et al. 2010). During the chronic phase it is only 
possible to detect the presence of T. cruzi by a serological method by detecting the presence 
of IgG anti-T. cruzi via an enzyme-linked immunosorbent assay (ELISA) or indirect 
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fluorescent antibody (IFA) test (Bern et al. 2011). The treatment of the chronic phase only 
concerns the treatment of the symptoms (Castro et al. 2006). 
New borne with congenital form are largely asymptomatic but in some cases they have severe 
life-threatening disease (Bern et al. 2009; Torrico et al. 2004). This form can be detected in 
early life by microscopy , just like in the acute phase via the visualization of the circulating 
tripomastigotes but also by molecular method via a PCR (Bern et al. 2011) . 
For an effective treatment of the disease , patients must be taken care of during the acute 
phase. The drugs used are benznidazole and nifurtimox and these two are effective against the 
extracellular form of T. cruzi which is present only during the acute phase. The side effects of 
the treatment are numerous and include among other things: anorexia, nausea, insomnia, 
nervous, convulsions, forgetfulness (Castro et al. 2006; Clayton 2010). 
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Figure 6: Life-cycle of Trypanosoma cruzi inside human host and Bugs (/rom Centers for 
Disease Control and Prevention) A tritomine ingested circulating blood parasites while taking a blood 
meal. The ingested trypomastigotes transform into the epimastigote form in the midgut of the bug where it 
replicates it then tums into the infective metacyclic trypomastigote in the hindgut . This form is able to go in 
the fece of the bug and enters into a mammalian host through a bite wound or mucosal membrane while the 
bug is taking a blood meal. The metacyclic trypomastigote is able to enter into various ce11s and inside 
tums into the amastigote form. lt then multiply and tums into trypomastigotes that reach the bloodstream or 
infect other ce11s and transform into amastigote. 
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lnterest of a cross-pathologies model 
The epidemiological data and the similarities between the hosts suggest that it is likely to find 
mammals infected with Brucella and Trypanosoma brucei. Those two pathogens cause 
zoonosis covering a large part of the globe and both infect cattle. Furthermore, if we enlarge 
the thematic to the impact of parasitic infection on the ability of the host to control 
brucellosis, it is important to note that many parasites cause asymptomatic infection and 
increase the risk to find co-infected host. 
T. brucei is also a good tool to modulate the immune environment of the mice infected with 
Brucella . The parasite is known to induce a strong Thl immune response with a IFNy-
producing CD4+ T cells which correspond to the immune response against Brucella (Liu et al. 
2015). Knowing that Brucella is a furtive bacterium that induces a weak immune response, it 
could be interesting to show if a strong Thl immune response could modulate the ability of 
Brucella to reach its niche and establish its chronicity. 
Objectives 
The aim of my master thesis was to generate an experimental model to study the impact of a 
cross-pathology on the ability of the mice to control the infection with Brucella and thus, to 
control the establishment of the bacteria to avoid the chronicity of brucellosis. Previous study 
in our laboratory have showed that Trypanosoma brucei infection reduce dramatically the 
number of Brucella melitensis in the spleen. We will identify the mechanisms implicated in 
this phenomenon. 
First, we will compare the impact of T. brucei on different species of Brucella (suis and 
abortus) and of another Trypanosoma species (T. cruzi) on B. melitensis to determine is an 
antigenic cross-reaction can explain the impact of the immune response against T. brucei on 
Brucella. 
Second, by using a battery of mice genetically deficient for key element of immune response, 
we will try to identify the immune mechanism induced by T. brucei implicated in the 




Materials and methods 
Ethics statement 
The procedures used in this study and the handling of the mice complied with current 
European legislation (directive 86/609/EEC) and the corresponding Belgian law "Arrêté royal 
relatif à la protection des animaux d'expérience du 6 avril 2010 publié le 14 mai 2010". The 
Animal Welfare Committee of the Université de Namur (UNamur, Belgium) reviewed and 
approved the complete protocol (Permit Number: 12-188). 
Mice 
Wild-type C57BL/6 mice and wild-type BALB/c mice were acquired from Harlan (Bicester, 
UK). IL-12p35_1_ C57BL/6 mice were acquired from Dr. B. Ryffel (University of Orleans , 
France) . TAP1-1- and MHCn-1- C57BL/6 mice were acquired from Jorg Reimann (University 
of Ulm, Ulm, Germany). CDl lc-DTR C57BL/6 mice were obtained from Dr. G. Holdenhove 
(Université Libre de Bruxelles, Belgium) and treated with diphtheria toxin (Sigma-Aldrich) . 
All wild-type and deficient mice used were bred and housed in an institutional conventional 
animal facility of the Gosselies campus of the Université Libre de Bruxelles (ULB, Belgium) 
under the ethical regulation of the ULB. All mice used were 6 to 8 weeks old. 
Mice infection with Bruce/la 
Bruce/la melitensis 16M and Bruce/la abortus 2308 strains are Nat KanR and constitutively 
expressing a rapidly maturing variant of the red fluorescent protein DsRed, the mCherry 
protein (mCherry-Br), under the control of the strong Bruce/la spp. promoter, PsojA. 
Construction of the mCherry-Br strains bas been described in detail in (Copin et al. 2012). 
Bruce/la strains were grown in biosafety level III laboratory facilities . Cultures were grown 
ovemight in a 2YT liquid medium (luria-Bertani broth with double quantity of yeast extract) 
at 37°C with shaking. The following day, the bacteria are harvested. Cultures are washed 
twice in RPMI 1640 (Gibco Laboratories) after centrifugation at 3500g for 10 minutes. The 
measurement of the OD at 600 nm allows to prepare the appropriate infectious dose after 
dilution in RPMI. The infectious doses were validated by plating serial dilutions of the 
inoculums . For intranasal infection, mice were anesthetized with a cocktail of Xylasine (450 
µé1/kg) and Ketamine (720 µé1/kg) in PBS before being inoculated intranasally with 2xl04 
CFU of B. suis, B. abortus or mCherry-expressing B. melitensis in 30µé1 of RPMI. For 
intraperitoneal infection, mice were inoculated with 2xl04 CFU of mCherry-expressing B. 
melitensis in 500µé1 of RPMI. For intradermal infection, mice were inloculated with 4xl04 
CFU of mCherry-expressing B. melitensis in 20µé1 of RPMI in the paw of the mice. The 
infectious doses were validated by plating serial dilutions of the inocula. 
Mice infection with Trypanosoma 
The pleomorphic AnTat 1 JE Trypanosoma brucei brucei and a dominant-negative adenylate 
cyclases (DNc) mutant were stocked in infected mice blood at -80°C. T. brucei infection is 
characterized by a multi-waves parasitemia development and each wave corresponds to a 
switch of the antigenic population. DNc mutant parasitemia displays no peak of infection. 
Parasitemia is evaluated by using a counting chamber and a light microscope before dilution 
in PBS to prepare the infectious dose. Mice were infected by intraperitoneal injection with 
5000 parasites/mouse in 200µé1 of PBS. 
') 1 
Conceming the infection with T. cruzi, we used the Tuhalen strain (genotype TcVI). Mice 
were infected by an intraperitoneal injection of 1000 parasites under the blood trypomastigote 
form. 
Injection of Diphtheria toxin 
48 hours before the selected time after infection, mice were injected in an intraperitoneal way 
with 200ng/mice of Diphtheria Toxin from Corynebacterium diphtheriae (Sigma-Aldrich) 
Harvesting of organs 
At the selected time after infection, mice were anesthetized with 250td of Isoflurane under a 
bell in order to take blood by a retro-orbital sampling. Then mice were sacrificed by cervical 
dislocations . Immediately after sacrifice, spleen, a lobe of the liver, one lung, thymus, brain, 1 
cm at the base of the tail, a piece of the muscle of the posterior leg, heart, bronchial draining 
lymphoid node , lesion from the paw, popliteal draining lymphoid node (for those two organs 
see A. Demars thesis) and one ovary) cells were collected for bacterial count. 
Bacterial count 
Organs were crushed and transferred to PBS/0.1 % X-100 triton (Sigma-Aldrich). We 
performed successive serial dilutions in RPMI to get the most accurate bacterial count and 
plated them on 2YT medium Kan+ for B. melitensis and B. abortus and on 2YT medium 
polymyxine+ for B. suis. The CFlJ were counted after 5 days of culture at 37°C. 
Cytofluorometric analysis 
Spleens were harvested after sacrificed of the mice and eut into small pieces in a six-well 
plate with a drop of a mix of DNase I (Sigma-Aldrich - 100 mg/ml) and collagenase (Roche-
400M and 1 U/ml). Spleens are then incubated for 30 min at 37°C, under 5% CO2 with lmL 
of collagenase/DNase. Cells are washed in RPMI 1640 and filtered with a bridal veil and a 
syringe into a Falcon 15 and are then incubated for 5 hours in lmL of RPMI 1640, 10% FCS 
with 1µ1/ml Golgi Stop (BD Pharmingen) at 37°C, under 5% CO2 • Cells are put ovemight in 
1 mL of rich medium (RPMI 1640 + decomplemented Foetal Bovine Serum + L-Glutamine + 
Non-essential amino acids + pyruvate sodium + Gentamycin 50mg/mL) after centrifugation at 
1400g for 7 minutes. The next day, cells are resuspended and 200td are put into a 96-well 
plate. Cells are washed twice with FACS buffer after centrifugation (2 minutes at 2000 RPM 
at 4°C). Cells are incubated with saturating doses of purified 2.4G2 (anti-mouse FcR; 
American Type Culture Collection) in 200 µlof PBS, 0.2% BSA, and 0.02% NaN3 (FACS 
buffer) for 20 min at 4°C to prevent Ab binding to the FcR. After being washed in FACS 
buffer, cells are incubated for 30 minutes in surface staining fluorescent mAb combinations in 
FACS buffer that were used to stain 3-5xl06 cells. We acquired the following mAbs from BD 
Biosciences: Fluorescein (FITC)-coupled HL3 (anti-CDl lc), FITC-coupled Ml/70 (anti-
CDllb), FITC-coupled 145- 2Cll (anti-CD3E), phycoerythrine (PE)-coupled 1-Nl-E (anti-
MHCII), PE-coupled RM4-5 (anti- CD4). After washing with FACS buffer and staining for 
cell surface markers , cells are fixed in PBS/1 % PFA for 15-20 min at 4 °C. They are 
permeabilized for 30 min using a saponin-based buffer (103 Perm/Wash in FACS buffer; BD 
Pharmingen) and stained with allophycocyanin-coupled XMGI.2 (anti- IFN-g; BD 
Biosciences) and with anti NOS2 (anti iNOS , Rabbit polyclonal IgG ; Santa-Cruz 
biotechnology). After final fixation in PBS/1 % PFA, cells were analyzed on a FACSCalibur 
cytofluorometer. No signal was detectable with isotype controls. The cells were analyzed on a 
FACSCalibur cytofluorometer. Dead cells and debris were eliminated from the analysis 
according to size and scatter. 
Statistical analysis 
We used a (Wilcoxon-) Mann-Whitney test provided by the GraphPad Prism software to 
statistically analyze our results. Each group of deficient mice was compared to wild-type 
mice. We also compared each group with each other and displayed the results when required. 
* ** *** **** Values of p < 0.05 were considered to represent a significant difference . , , ' 
denote p<0.05, p<0.01, p<0.001, p<0 .0001, respectively. 
RESULTS 
Results 
1. Characterization of the impact of T. brucei infection on B. 
melitensis infection in mice 
1.1 Bruce/la melitensis persist in CDllc+ reservoir cells in spleen providing a 
resistance to the immune response 
The kinetic of B. melitensis in C57BL/6 mice have been established in the lungs, spleen and 
the liver following an intranasal infection with 2xl04 CFU of mCherry-B. melitensis. The 
bacteria persist until 12 days post infection in the lungs of the mice whereas the spleen and 
the liver are colonized from 5 days post infection. From 28 days post infection, the bacteria 
persist only in the spleen where it establishes a niche to persist for a long period (Hanot 
Mambres et al. 2016). By microscopie analysis in highly susceptible IL-12p40_,_ BALB/c 
mice, it has been shown that B. melitensis, during the chronic phase of infection, resides in 
reservoir cells, express a specific phenotype (CDl lc+ CD205+ Arginase+) (Hanot Mambres et 
al. 2015). Nevertheless, a microscopie analysis of infected cells in resistant mice is impossible 
due to the low number of Brucella persisting in their spleen. As an alternative, we used DTR-
CDl lc C57BL/6 mice. These mice express diphtheria toxin (DT) receptor under the control 
of CDl lc promoter. When those mice are injected with DT, depletion of CDl lc+ cells is 
induced by apoptosis and the number of CDl lc+ cells remain low for 2 days. This specific 
depletion is allowed by the fact that murine cells are not sensitive to DT contrary to primate 
cells (Van Blijswijk et al. 2013; Jung et al. 2002). In order to determine if Brucella resides in 
CDl lc+ reservoir cells, DTR-CDl lc C57BL/6 mice were infected by an i.n route with 2xl04 
CFU of mCherry-B. melitensis and 26 days post infection, they were injected intraperitoneally 
with 10 ng of DT in 500 µlof PBS while the control group was injected with 500 µlof PBS 
alone. 48 hours later, at day 28 post infection with Brucella, mice were sacrificed by cervical 
dislocation and the spleens were harvested. Half of them were used to perform a flow 
cytometry analysis and the other half were used to count the bacterial load remaining in the 
spleens. The flow cytometry analysis confirmed that the injection of DT induces a drastic 
elimination of CDl lc+ in infected mice (Figure 7.A). The depletion of those cells leads to a 
drastic drop of the bacterial load when compared to the control group (Figure 7.B). A 
comparable effect is also observed at 50 days post infection (Figure 7.B). Those results 
suggest that Brucella melitensis resides in CDllc+ reservoir cells in the spleen of wild type 
C57BL/6 mice during the chronic phase of infection. 
Following an i.n. infection with Brucella in wild type C57BL/6 mice, a protective memory T 
cell response is set up. When a second infection with Brucella occurs, this response is able to 
rapidly control the newly arrived bacterial load and to eliminate it (Hanot Mambres et al. 
2016). In order to determine if the protective memory T cell response impact the bacterial 
load from the first infection that persists in reservoir cells in the spleen, we compared the 
CFU level of a wild type B. melitensis with the CFU level of mCherry-B. melitensis in the 
spleens of mice from 3 different group. As described in Figure 8.A, the first group was only 
infected by an i.n . route with mCherry-B. melitensis at day 45, the second group was firstly 
infected intranasally at day 0 with wild type B. melitensis and was challenged at day 45 with 
mCherry-B. melitensis. The third group was only infected at day 0 by an i.n. route with wild 
type B. melitensis. At day 73, all mice were sacrificed and spleens harvested in order to count 
the bacterial load. As expected, mCherry-B. melitensis challenge is well controlled by 
immunized mice from the second group when compared to non-immunized mice from the 
first group. Interestingly, the bacterial load of wild type B. melitensis was comparable 
between the challenged group and the unchallenged one, meaning that the memory immune 
response is able to control a second infection but does not impair Brucella when it is already 
established in CDl lc+ reservoir cells (Figure 8.B). Those results suggest that the CDl lc+ 
reservoir cells confer a protection to Brucella against the protective memory response 
allowing the persistence of the bacteria in the host. 
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Figure 7: Brucella persists in CDlJc+ reservoir cells in spleen of chronically infected wild type 
C57BL/6 mice. DTR-CDl le C57BL/6 mice were infected by an i.n. route with 2xl04 CFU of mCherry-B. 
melitensis. 26 days post infection, they were injected intraperitonally with 10 ng of diphtheria toxin in 500 
µ,e of PBS or with PBS alone for the control group. Two days after DT injection, mice were sacrificed by 
cervical dislocation to harvest the spleen. A. Flow cytometry analysis of the expression of CDl lc and 
MHCII on spleen cells. Data show a representative dot plot from individual mice. B. The data represent the 
number of CFU per gram of spleen for each group of mice at indicated time post infection. n denotes the 
number of mice used in each group. The grey bar represents the means . ** , p < 0.01 ; *** , p < 0.001. 
Detection threshold = 10 CFU. 
1.2 T. brucei infection reduces the number of Brucella persisting in spleen 
The previous results show that the protective immune response induced by a second 
exposition to Brucella is able to control this second infection but this immune response is not 
strong enough to impair the bacterial load from the first infection established in reservoir cells 
in the spleen of the mice. We wanted to determine if a strongest inflammatory response is 
able to destabilized B. melitensis when already established in its reservoir cells. To do so, we 
used T. brucei which is a parasite known to induce a strong inflammatory immune in order to 
test this hypothesis. In order to determine whether T. brucei impacts the course of infection of 
B. melitensis, wild type C57BL/6 mice were infected by an intranasal (i.n.) route with 2xl04 
CFU of mCherry-B. melitensis. At 7 days post Brucella infection, mice were injected 
intraperitoneally with 5000 parasites. At selected lime post infection, mice were sacrificed by 
cervical dislocation and spleen were harvested, crushed and plated in order to determine the 
bacterial load of each organ by plating. The results show that T. brucei infection induces a 
significant decrease of the bacterial load in the spleen. At 5 days post co-infection with the 
parasite, a decrease of 1-1,5 log of the CFU in co-infected mice is already observable when 
compared to mice infected with B. melitensis alone. This result is still observable at days 12 
and 28 post infection with B. melitensis when co-infected. At 21 days post co-infection, the 
bacterial load observed a serious drop of 3 log and B. melitensis CFV levels are under 
detection threshold (10 CFU / spleen) in the majority of co-infected mice. Those results 
suggest that the immune response induced by T. brucei infection is able to destabilize 
Brucella's reservoir cells and thus, allowed the elimination of the bacteria in the spleen 
(Figure 9). When taking into account that the localization of B. melitensis in spleen is 
different depending on the route of infection (Hanot Mambres et al. 2016), we performed a 
similar experiment to compare the impact of T. brucei on B. melitensis persistence when 
injected in an i.p. mode and similar results were obtained (Figure 9.C). 
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Figure 8: reservoir cells confer a protection to Brucella against the protective immune response. 
Wild type C57BL/6 mice were infected intranasally with 2xl04 CFU of wild type B. melitensis at day 0 and 
/ or mCherry-B. melitensis at day 45. At selected time, mice were sacrificed to harvest the spleens as 
described in A . B. The data represents the CFU per spleen for each group at selected time post infection. n 
denotes the number of mice used in each group. The grey bar represents the means. **, p < 0 .01 ; ***, p < 
0.001. Detection threshold = 10 CFU. 
In order to determine if the elimination of B. melitensis following an infection with T. brucei 
observed is due to an antigenic cross-reaction between B. melitensis and T. brucei, we tested 
if T. brucei was able to impact the control of the infection in the spleen with two other 
Brucella species that also affect humans: B. abortus and B. suis; as for B. melitensis, T. brucei 
induces a drop of the bacterial load when the mice are infected with B . abortus but also when 
infected with B. suis and the decrease of the bacterial load is as important as it is for B. 
melitensis. We also tested the impact of an infection with T. cruzi on the control of an 
infection with B. melitensis. T. cruzi is an intracellular protozoan parasite presenting only one 
peak of parasitaemia 20 days post infection in mice and presents a rate mortality of about 30% 
whereas T. brucei is characterized by parasitaemia every 5 days corresponding to the switch 
of its VSG (Rudenko 2011; Lalonde & Holbein 1984). The vector of those two parasites are 
also different and they present their own pathogenicity . Following a co-infection with T. cruzi 
a drastic drop of B. melitensis in the spleen of co-infected mice was also observable when 
compared to mice infected with B. melitensis alone (Figure 10) . 
These results demonstrate that the elimination of Brucella following Trypanosoma infection 
is not due to an antigenic cross-reaction. 
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Figure 9: impact of T. brucei co-infection on the course of intranasal B. melitensis infection in 
mice. Wild type C57BL/6 mice were infected intranasally with 2xl04 CFU of mCherry-B. melitensis and 
were injected 7 days later intraperitoneally with 5000 T. brucei in 200 µR of PBS or with PBS alone for the 
control group. At the selected times post infection , mice were sacrificed by cervical dislocation to harvest 
the spleens (see panel A.). B. The data represents the CFU per gram of spleen for each group at selected 
time post infection. C. Wild type C57BL/6 mice were infected intraperitoneally with 4x 104 CFU of 
mCherry-B. melitensis and were injected in i.p. 7 days later with 5000 T. brucei 200 µR of PBS or with PBS 
alone. n denotes the number of mice used in each group. The red bar represents the means. ** , p < 0.01 ; 
***, p < 0.001. Detection threshold = 10 CFU. 
1.3 Elimination of Bruce/la fol lowing T. brucei infection require functional IL-12 / 
IFNy signaling pathways 
IFNy - producing CD4+ T cells plays a central role in the protective immune response against 
B. melitensis. The impact of T. brucei infection on the control of B. melitensis was compared 
in wild type and in multiple deficient mice: co3-1- , yôTCR1- and IL-lR1- were performed 
before I arrived in the team and MHCn-1-, IL-12p3s-1- and TAP1 -1- . It has been shown that T. 
brucei was able to induce an elimination of B. melitensis in yôTCR1- , IL-1R1- and TAP1 -1-
mice but not in co3-t-, MHCn-1- and IL-12p3s-1- mice (Figure 11. A). Those results suggest 
that the elimination of B. melitensis by T. brucei depends on the host immune response and 
required a functional IL-12 / IFNy signaling pathways and the CD4+ T cells. 
We also analyzed by flow cytometry the frequency of IFNy and iNOS-producing cells in the 
spleen of wild type and deficient mice co-infected with T. brucei and B. melitensis or infected 
with B. melitensis alone, as nitric oxide produced by iNOS/NOS2 is well known to be 
produced in response to IFNy but also described as disadvantaging B. melitensis growth in the 
spleen (Copin et al. 2007) (Figure 11.B-C).The results show that a strong increase of IFNy 
and iNOS - producing cells is induced by the presence of T. brucei. The production of IFNy 
is principally due to CD3+ CD4+ T cells. In IL12p35_1_ mice , a significant reduction of IFNy+ 
and iNOS+ cells frequency is observable when compared to wild type mice. An interesting 
point is that there is no significant difference between the frequency of IFNy and iNOS -
')Q 
producing cells in the spleen of TAPI _,_ mice (deficient for CD8+ T cells and able to clear 
Brucella during co-infection) and MHCrr-'- mice (deficient for CD4+ T cells and unable to 
clear the bacteria), showing that the control of B. melitensis infection when co-infected with 
T. brucei required a functional IL12p35-IFNy signaling pathway but also to the presence of 
CD4+T cells . 
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Figure JO: impact ofT. brucei co-infection on B. suis and B. abortus infection and impact ofT. 
cruzi on B. melitensis infection. Wild type C57BL/6 mice were infected intranasally with 2x103 CFU of 
B. abortus (A) or B. suis (B) and were injected 7 days later intraperitoneally with 5000 T. brucei in 200 µ,e 
of PBS or with PBS alone for the control group. C. Wild type C57BL/6 mice were infected i.n. with 2xl04 
CFU of mCherry-B. melitensis and were injected in i.p. 7 days later with 5000 T. cruzi in 200 µ,e of PBS or 
with PBS alone. Mice were sacrificed 28 days post Brucella infection to harvest the spleens. The data 
represent the number of CFU per gram of spleen. n denotes the number of mice used in each group . The red 
bar represents the means. *** , p < 0.001 ; ****, p < 0.0001 . Detection threshold = 10 CFU. 
1.4 Attenuated T. brucei mutant but not killed parasite is able to reduce Bruce/la 
infection 
We have shown previously that T. brucei induces a strong Thl inflammatory response 
infected mice. This response allowed the control of B. melitensis infection in co-infected 
mice. In order to determine if the intensity and the duration of the Thl response are essential 
parameters, we compared the ability of wild type T. brucei and a dominant-negative adenylate 
cyclases (DNc) T. brucei mutant. The DNc T. brucei mutant shows a lower parasitaemia 
inducing a weaker inflammatory immune response. This less strong immune response allowed 
an increase of the survival time of infected mice when compared to mice infected with wild 
type T. brucei (Salmon et al. 2012). 
The elimination of B. melitensis in co-infected mice was observable in both cases: when co-
infected with wild type but also when co-infected with the mutant (Figure 12.A). Those 
results suggest that a low persistence of parasite is able to complete the elimination of B. 
melitensis. In previous experiment, mice were repeatedly injected with a lysate of T. brucei 
and no effect on the control of B. melitensis infection were observable meaning that living 
parasites seem to be needed. 
At early time post co-infection, the frequency of IFNy - producing cells in the spleen is lower 
in mice infected with DNc than those infected with wild type T. brucei. This might be 
translated by a slower effect of the mutant on the control of B. melitensis in the spleen due to 
less IFNy (Figure 12.B). 
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Figure 11: elimination ofBrucella during T. brucei infection requires IL-12 and CD4+ T cells. 
Wild type and multiple deficient C57BL/6 mice were infected intranasally with 2xl04 CFU of B. melitensis 
and were injected 7 days later intraperitoneally with 5000 T. brucei in 200 !.d of PBS or with PBS alone for 
the control group. Mice were sacrificed 28 days post Bruce/la infection to harvest the spleens. A. The data 
represent the number of CFU per gram of spleen . n denotes the number of mice used in each group. The red 
bar represents the means. ***, p < 0.001. Detection threshold = 10 CFU. B, C. The data represents the 
frequency of IFNy and iNOS producing cells in spleen as determined by flow cytometry analysis. Control 
group corresponds to naïve mice receiving PBS only . **, p < 0.01; *** , p < 0.001. 
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Figure 12: attenuated dominant negative adenylate cyclase (DNc) mutant of T. brucei induces 
elimination of Brucella. Wild type C57BL/6 mice were infected intranasally with 2xl04 CFU of mCherry-
B. melitensis and were injected 7 days later intraperitoneally with 5000 wild type T. brucei or attenuated 
DNc mutant of T. brucei in 200 µi of PBS or with PBS alone for the control group. Mice were sacrificed at 
selected times post Brucella infection to harvest the spleens. A. The data represent the number of CFU per 
gram of spleen. n denotes the number of mice used in each group. The red bar represents the means. 
Detection threshold = 10 CFU. B. The data represent the mean of the frequency ofIFNy producing cells in 
spleen from 5 individual spleens as determined by flow cytometry analysis for each group. Control group 
corresponds to naïve mice receiving PBS only. *, p < 0.05 ; ** , p < 0.01; ***, p < 0.001. 
1.5 Confirmation of t he implication of IL-12p35 pathway in the elimination of 
Bruce/la following the injection of wi ld type T. brucei, attenuated T. brucei 
mutant and T. cruzi 
Previous experiments show that the protective memory immune response is not strong enough 
to destabilized Brucella when it is already established in its reservoir cells in spleen. 
However, we show that a strongest inflammatory response induced by the injection of wild T. 
brucei, attenuated T. brucei mutant but also that the injection of T. cruzi, indicating that it is 
not an antigenic cross-reaction, allowed the elimination of the bacteria in the spleen of co-
infected mice. 
Here we confirm the implication and the requirement of a functional IL-12p35 pathway in the 
elimination of B. melitensis in mice regardless of the inducer of the strong inflammatory 
response. To do so we infected by an i.n . route wild type C57BL/6 mice and IL-12p35 _,_ 
C57BL/6 mice with 2xl04 CFU of mCherry-B. melitensis. Wild type C57BL6 and IL-12p35 _,_ 
'l 1 
C57BL/6 mice were both divided into 4 groups that were injected in i.p. 7 days after Bruce/la 
infection respectively with: PBS alone for the control group, 5000 wild type T. brucei, 5000 
attenuated T. brucei mutant or 1000 T. cruzi. As expected, the elimination of Bruce/la is 
observable in wild type mice regardless of the parasite injected when compared to the control 
group. In mice deficient for the IL-12 pathway, the bacterial load remains equal to the control 
group in co-infected mice. Those results confmn the central and even essential role of the IL-
12p35 pathway in the control of Brucella's infection regarding that IL-12p35·1· mice are not 
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Figure 13: wild type T. brucei , attenuated dominant negative adenylate cyclase (DNc) mutant of 
T. brucei and T. cruzi induce elimination o/Brucella on a IL-12p35-depending pathway. Wild type and 
IL-12p3S-1• C57BL/6 mice were infected intranasally with 2xl04 CFlJ of mCherry-8. melitensis and were 
injected 7 days later intraperitoneally with , respectively, PBS alone for the control group, 5000 wild type T. 
brucei, attenuated DNc mutant of T. brucei in 200 µP of PBS or 1000 T. cruzi in 200 µP of PBS. Mice were 
sacrificed 28 days post Brucella infection to harvest the spleens. The data represent the number of CFU per 
gram of spleen. n denotes the number of mice used in each group. The red bar represents the means. 
Detection threshold = 10 CFU. ***, p < 0.001. 
Ail these results show the behavior of Bruce/la in the spleen of mice following an i.n. 
infection but the spleen is not the only organ colonized by the bacteria. It could be then 
interesting to characterized the dissemination of this pathogen in order to target other organs 
in which Brucella is also able to establish itself to persist for a long time. 
2. The route of infection affect the dissemination of Bruce/la in 
m1ce 
It has been shown that following an i.p. infection in mice, Brucella spreads in a systemic way 
and is rapidly found in almost all organs (Rajashekara et al. 2005). This mode of infection is 
the most used in laboratory because of its ease of use and the rapidity of the bacteria's 
spreading but it is not the most representative of what happens in nature. Here we compared 
with i.p. two other route of infection in mice that are more representative of some 
physiological routes of infection: the intradermal (i.d.) and the intranasal (i.n.) infection, to 
put them on parallel with the i.p. model. The i.d. and i.n. models present a local dissemination 
of Brucella in the host whereas the i.p. model presents a systemic dissemination (Figure 14). 
In order to compare those 3 routes of infection, we divided wild type C57BL/6 mice into 3 
different groups and each group corresponds to one route of infection. The i.p. group and i.n. 
group received approximatively the same infectious dose of mCherry-B. melitensis. I hour 
post infection, in the i.p . model, all the organs tested were positive for Brucella with a 
bacterial load from 1 to 3 log except the muscle from the posterior leg, the tail, the popliteal 
draining lymph node and the footpad where the i.d. group was injected (Figure 15). While in 
the i.d. the footpad, the blood and surprisingly, the spleen and the liver were also positives . In 
the i.n. models, only the lungs: the way of entry of the bacteria, were positives and are the 
only organs colonized until the day 5 post infection when the bronchial draining lymph node 
starts to be colonized by Brucella. At day 1 post infection, following an i .p. infection, the 
blood, the spleen and the liver are highly colonized with up to 5 log of bacteria and only the 
muscle and the popliteal lymph node remain free of bacteria or at least with a bacterial load 
under the threshold of detection (10 CFlJ) . In the i.d. model, the paw remains highly infected 
and the popliteal draining lymph node becomes colonized. The bacterial load in spleen and 
the liver is 1 log higher than at 1 hour post infection while the bacterial load in the blood 
drops to 1 log. At day 5 post infection, in the i.p. model , all the organs tested are colonized 
and the blood is the only one where a drastic drop of 3 log is observable whereas the bacterial 
load in other organs is either stable either higher. Following an i.d. route of infection, about 4 
log of B. melitensis are detectable in the spleen, the liver, the paw and the popliteal draining 
lymph node. Brucella is also detectable in the tail and the muscle of the mice but at a lower 
level and in the blood, the bacteria is now undetectable. After 12 days of infection, following 
an i.p. route of infection, a slight decrease of the bacterial load is observable in every organs 
and in the blood and the muscle, it drops under the threshold. In the i.d. model, the spleen and 
the popliteal draining lymph node remain highly colonized while a decrease is observed in the 
liver and the paw of the mice and the bronchial draining lymph node is newly infected with 
about 2 log. Following the i.n. route of infection, the spleen, the liver and the thymus are 
newly colonized and in the thymus, the bacterial load persist until the day 50 where it 
becomes undetectable while in the spleen the bacterial load remain stable even at day 50 post 
infection and the same is observable for the bronchial draining lymph node. In the liver, it is 
the only transitory: it is no more observable at day 28 post infection. Following an i.d. 
infection at 28 days post infection, the thymus is colonized but only transiently because at day 
50 post infection, no bacteria remain detectable, the bacterial load in the spleen and the 
bronchial draining lymph node stabilized and remain equal at day 50 post infection whereas it 
drops in the paw and it decreases steadily in the popliteal draining lymph node until the day 
50. At day 28 post infection following an i.p. route of infection, the spleen remains highly 
colonized with a bacterial log of about 4 log that is still detectable at day 50, for the thymus, 
the bronchial draining lymph node and the popliteal draining lymph node it is the same 
schema but with, respectively, a bacterial load of 3 log, 2 log and 1 log (for more data, see 
Supplementary data 1). 
In summary, these results demonstrated that if Bruce/la disseminate throughout the organism 
in each model, its profile of persistence in organs is strongly depending on the way of 
infection. As the pathology associated to brucellosis is generally depending on local 
inflammation induced by the persistence of the bacteria, our work suggests that the way of 
infection can influence the pathology induced by Brucella in host. 
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Figure 14: Brucella dissemination depends on its route of infection in C57BL/6 mice. C57BL/6 
mice infected were infected by an i.n. or i.p. route with 2xl04 CFlJ and on i.d . route with 4xl04 CFU of 
mCherry-B. melitensis. At selected times post infection mice were anesthetized to take blood and were then 
sacrificed by cervical dislocation to harvest multiple organs: the thymus, the spleen , one lobe of the liver, 
one Jung, the bronchial draining lymph node , the brain, one ovary, the heart, 1 cm of the muscle of the 
posterior leg , 1 cm at the base of the tail , the lesion at the footpad and the popliteal draining lymph node . 
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Figure 15: Brucella dissemination on the lung, spleen and footpad of C57BL/6 mice following 
i.p., i.n. and i.d. infection. C57BL/6 mice infected were infected by an i.n. or i.p. route with 2xl04 CFU 
and on i .d. route with 4x 104 CFU of mCherry-B. melitensis. At selected times post infection mice were 
anesthetized to take blood and were then sacrificed by cervical dislocation to harvest multiple organs: the 
thymus , the spleen, one lobe of the liver, one Jung, the bronchial draining lymph node , the brain , one ovary , 
the heart, 1 cm of the muscle of the posterior leg, 1 cm at the base of the tail, the lesion at the footpad and 
the popliteal draining lymph node. The data represent the number of CFU per A. Jung, B. spleen, C. 
footpad . n denotes the number of mice used in each group. The red bar represents the means . Detection 
threshold = 10 CFU. *, p < 0 .05 ; **, p < 0.01 ***, p < 0.001 . 
DISCUSSION 
Discussion 
Immunological experimental models are often very reductionist by studying the effect of only 
one parameter on the dynamic of a complex system and thus providing a vision far from the 
reality. In reality, the ability of the host to face an infection is depending on so many 
parameters that the outcome of the battle is unpredictable at individual level. Identifying those 
parameters constitutes a real challenge and could offer a better follow-up of the patient and a 
better control of the spreading of the disease. In the literature, many factors are described to 
modulate the immune response of the host, such as genetic, alimentation, microbiota, 
psychological stress, past immune history , chronic infection ... All those factors can influence 
positively or negatively the control of an infection (Muraille 2016) 
During my master thesis, we got interested on the impact of a co-infection on the ability of the 
host to control an infection with Brucella. To do so, we developed a mice model in which we 
study the impact of T. brucei infection on the course of B. melitensis during its chronic phase 
of infection. The long term persistence of the bacteria renders it a good model to study the 
impact of a co-infection on a chronical infectious disease. 
Brucella is an intracellular Gram negative bacteria responsible for a worldwide zoonosis: 
brucellosis. 500.000 new human cases are diagnosed each year and it causes huge economical 
issue by causing abortion and infertility in animals (Pappas et al. 2006). Without treatment, 
brucellosis tums into a chronic disease allowing the bacteria to persist in the host for his 
lifetime. This persistence makes it likely that a host infected with Brucella has to face several 
other infections. Brucella bas acquire strategies to interfere with its recognition by the 
immune by the immune system and to neutralize immune effectors. As soon as it enters into 
the host cell, Brucella is able to divert the intracellular traffic to avoid degradation by the 
phagolysosome and then to tum toits advantage de metabolism of the host cell. 
Our research group bas recently developed an almost physiological model of intranasal (i.n.) 
Brucella infection in mice (Hanot Mambres et al. 2016). Mice receive intranasally 2xl04 CFU 
of B. melitensis, rnimicking the infection by the inhalation of aerosol. B. melitensis bas been 
chosen among all Brucella's species because it is the most frequently isolated in human 
(Young 2002). Following an i.n. infection, bacteria persist in the lungs of the mice until 12 
days post infection and the spleen and the liver are infected from 5 days post infection. 
Brucella is able to persist in the spleen for a long period, at least until 50 days post infection, 
but not in the liver. An early immune response controlling bacteria growth bas been identified 
in the lungs of infected rnice as being dependent on IL-17RA, yô+ T cells, cos+ T cells. The 
late immune response in the lung and the spleen is mainly depending on IFNy - CD4+ T cells 
response (Hanot Mambres et al. 2016). As it bas been shown by Hanot Mambres in the spleen 
of highly susceptible IL-12p40-1- BALB/c mice, Brucella resides in reservoir cells displaying a 
specific phenotype. These cells are CDl lc+ CD205+ arginase 1 + and are lipid rich (Hanot 
Mambres et al. 2015). We hypothesized that these reservoir cells could confer a protection 
against the protective memory response to Brucella and allowed the bacteria to persist in the 
host through its lifetime. 
During my master thesis, we have first confirmed that the reservoir cells of Brucella 
expressed CDl lc+ in resistant C57BL/6 mice by using CDl lc-DTR mice. We used those 
mice as an alternative because the remaining level of Brucella in the spleen of resistant mice 
'l '7 
is too low to be observed by microscopy analysis. CDllc-DTR rnice express a diphtheria 
toxin (DT) receptor under the control of CDl lc promoter. An intraperitoneal injection of DT 
induces the depletion of CDllc+ cells by inducing their apoptosis (Van Blijswijk et al. 2013; 
Jung et al. 2002). The depletion of those cells is translated by a serious drop of the bacterial 
load in the spleen of the mice. Using this technique could allow us to identify the phenotype 
of reservoir cells in other organs where Brucella is able to persist such as the branchial 
draining lymph node where the bacteria is also able to persist for a long time. But the adverse 
effect of CDllc-DTR mice is that the injection of DT in mice induces a small inflammatory 
response that could modify the physiology of the rnice. The mechanism by which Brucella 
dies is still unknown but we can hypothesized that when the reservoir cells die by apoptosis, 
bacteria are released making them accessible to the immune system and killed by the 
inflammation generated by the apoptosis. But we can also hypothesized that the death of the 
cell leads to the death of the bacteria because of a lack of nutrients. 
We also demonstrated that reservoir cells provide a resistance against the protective Brucella 
specific memory response as Brucella challenge strain but not established strain is eliminated 
in chronically infected mice. Thus, infected mice develop a specific immune response able to 
control and eliminate a new infection by Brucella but unable to eliminate established 
infection. 
As Brucella is well known to display various mechanisms allowing to escape both innate and 
adaptive immune response, we develop a co-infection model with T. brucei in order to 
analyze the effect of a strong, non antigen, specific inflammatory immune response on the 
persistence of B. melitensis. We observed that a co-infection with T. brucei in mice previously 
infected with B. melitensis strongly increase their ability to control Brucella infection. This 
result is very surprising as Trypanosoma 's, are well known to induce an immunosuppressive 
effect (Murray et al. 1974) lt might be due to a stronger Thl immune response than a Th2 or 
the immunosuppressive effect could appear later in the kinetic of infection of T. brucei and 
then could be visible later. This last hypothesis is, at that time, impossible to confirm or 
invalidate due to the fact that mice end up dying when infected with T. brucei. 
Cytofluorometry analysis highlighted that this elimination following the co-infection by the 
parasite is associated a high frequency ofIFNy producing CD4+ T (Thl) cells. Co-infection of 
rnice deficient for IL-12, which is required for the production of IFNy, are notable to clear 
the bacteria confüming that the Th 1 immune response is well required for the elimination of 
Brucella. However, co-infection does not eliminate Brucella in MHCff'- rnice in despite of a 
high frequency of IFN-y+ CD8+ T cells, suggesting that a functional IL-12/IFNy signaling axis 
is required but not sufficient to clear Brucella. Additional unknown effector mechanisms, 
provided by CD4+ T cells, appear also necessary. It could be interesting to transfer IFNy -
producing CD4+ T cells induced by a T. brucei infection in rnice infected with Brucella to 
determine if these cells mediating the Thl response are able alone to increase the control of 
the infection by Brucella. lt is interesting to remark that co-infection with a strongly 
attenuated T. brucei mutant (DNc T. brucei mutant), which induces a weaker inflammatory 
response than the wild type T. brucei, is also able to elirninate Brucella in spleen, suggesting 
that the level of the inflammatory response is not a limiting factor. 
In order to better characterize the mechanism of the elimination of B. melitensis by T. brucei, 
we performed the same co-infection experiment but with another Trypanosoma species: T. 
cruzi. This protozoan parasite has a completely different life cycle than T. brucei and shares 
no common antigen. The only common point between those two species is that they botb 
induce a strong Thl inflammatory immune response. We observed that mice co-infected with 
T. cruzi were also able to better control the bacterial infection by inducing an important 
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production of IFNy by the CD4+ T cells. The similar reduction of the bacterial load that was 
observed in the spleen when mice were co-infected with T. cruzi means that the elimination of 
Brucella is not due to an antigenic cross-reaction but well due to an " antigen unspecific" 
effect depending of the Thl response induced by the parasite. We also tested the impact of a 
co-infection with T. brucei on the control of an infection with two other species of Brucella 
that can also affect humans: B. abortus and B. suis, in order to determine if we could 
generalize the effect of T brucei to Brucella in general. The elimination of those two species 
was notas important as with B. melitensis. This partial eradication might be due to the fact 
that the bacterial load in the spleen of mice was higher with B. abortus and B. suis than with 
B. melitensis. 
In summary, previous studies (Copin et al. 2012; Hanot Mambres et al. 2015) and the present 
work showed that Brucella resides in spleen, in a specific CDl lc+ reservoir cells that is little 
accessible to immune effectors activated during a re-infection with the bacteria. The infection 
by T. brucei or T. cruzi might induce a strong Thl immune response able to destabilize 
Brucella's niche making the bacteria accessible to the immune effectors. This could due to the 
fact the inflammatory response is so important that it induces a tissue alteration such that the 
reservoir cells become accessible. A microscopy analysis of the spleen of the co-infected mice 
could confirm or invalidate this hypothesis . As shown by Copin, Brucella resides in 
granuloma that acts like fortress against immune effectors, making the access to the infected 
cells more complicated (Copin et al. 2012). Granulomas are dynamic structures set-up by the 
host when unable to clear the pathogen. It is composed of macrophages surrounded by T cells 
lymphocytes in order to reduce the dissemination of the pathogen but in some cases it could 
also facilitate the proliferation of the pathogen before its dissemination (Davis & 
Ramakrishnan 2009; Ramakrishnan 2012). In the case of an intranasal infection with 
Brucella, granulomas are localized in the white pulp in the spleen and are composed of 
macrophages and infected dendritic cells surrounded by T cells (Hanot Mambres et al. 2016). 
T. brucei might be able to destroy this fortress, opening a way to the infected cells for the 
immune effectors, allowing the elimination of Brucella in co-infected mice. 
Our co-infection model constitutes an opportunity to identify mechanisms involved in the 
elimination of Brucella's reservoir cells and maybe could lead to the discovery of new 
therapeutic strategies for brucellosis not dependent on antibiotic treatment, which is heavy at 
this time. But one thing to keep in mind is that mice are not the natural host neither for 
Brucella nor for T. brucei. However, those two pathogens infect cattle as well as humans. 
Brucellosis is a widespread pathology in human but also in animals which maximize the 
chance to find host infected with Brucella affected with another pathology. If we take a look 
at the distribution of brucellosis and the African trypanosomiasis, we can see that endemic 
regions for Trypanosoma are not endemic for brucellosis. That could be explained by our 
results showing that an infection with T. brucei drastically reduces Brucella. But the 
prevalence of brucellosis in regions touched by trypanosomiasis is also probably reduced due 
to the fact that breeding is less spread in those regions because of the acute risk of 
transmission of the parasite. 
By comparing the dissemination Brucella following different route of infection 
(intraperitoneal, intranasal, intradermal), we observed that the infectious model has a great 
impact on the nature of chronically infected organs and by consequence, potentially, on the 
pathology of brucellosis. Following an intraperitoneal infection, the dissemination of the 
bacteria follows a systemic way when it was a local dissemination when infecting in an 
intranasal or in an intradermal way. During this mas ter thesis, we focused on the impact of the 
co-infection with T. brucei on the bacterial load in the spleen. It could be interesting to 
'lO 
determine if those results can be generalized to other organs. Following an intranasal 
infection, we observed that Brucella was able to persist for a long time in the spleen and the 
bronchial draining lymph node. The bacteria were also able to persist in those organs 
following and intradermal infection but also in the popliteal draining lymph node which is 
coherent knowing that it drains the paw which was the way of entry of the bacteria in this 
model. Whereas following an intraperitoneal infection with Brucella, in addition to the lymph 
nodes and the spleen, the thymus remains infected on a long period. The impact of an 
infection with T. brucei on Brucella in those other organ could be interesting to study. 
In conclusion, we can say that those results show a real effect of a co-infection and that cross-
pathologies have a real impact on the immune response and it is important to take them into 
account. Discover the mechanisms could lead to the identification of therapeutic strategies 
and not only for Brucella. Those co-infection model could be extended to other infectious 
model such as Mycobacterium tuberculosis or other pathologies presenting public health 
issues . It could be a new approach to identify therapeutic targets or, in the case of a negative 
effect of the cross-pathology, a marker of higher susceptibility. 
It could be also interesting to be able to predict the future of an affected patient and to be able 
to personalize its treatment by taking into account its immunological status. 
,1() 
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Supplementary data 1: Course ofBrucella infection in C57BL/6 micefollowing i.p., i.n. and i.d. 
infection. C57BL/6 mice infected were infected by an i.n. or i.p. route with 2xl04 CFU and on i.d. route 
with 4xl04 CFU of mCherry-B. melitensis. At selected times post infection mice were anesthetized to take 
blood and were then sacrificed by cervical dislocation to harvest multiple organs: the thymus, the spleen, 
one lobe of the liver, one Jung, the branchial draining lymph node, the brain, one ovary, the heart, 1 cm of 
the muscle of the posterior leg, 1 cm at the base of the tail, the lesion at the footpad and the popliteal 
draining lymph node. The data represent the number of CFU per A. Jung, B. spleen, C. one lobe of the 
liver, D. branchial draining lymph node, E. thymus, F. 1 cm of muscle, G. footpad lesion, H. popliteal 
draining lymph node, I. 1 cm at the base of the tail, J. brain, K. a ml of blood, L. heart, M. one ovary. n 
denotes the nurnber of mice used in each group. The red bar represents the means. Detection threshold = 10 
CFU. *, p < 0.05; **, p < 0.01 ***, p < 0.001. 
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